A Target Enabling Package (TEP) for Classic Galactosemia drug discovery, created by G.A. Bezerra at the University of Oxford. It provides protein reagents, biophysical assays, and structural information to understand the defective GALT enzyme and explore chemical interventions targeting GALK1. The dataset is published under an Open Access (green) license.
Use Cases
- Understanding the molecular basis of Classic Galactosemia based on the provided structural information for the GALT enzyme.
- Identifying chemical starting points for drug discovery based on the described assays targeting the upstream enzyme GALK1.
- Exploring substrate reduction therapy strategies based on the plan to mitigate the GALT defect through GALK1 intervention.
Strengths
- Provides a multi-faceted resource including protein reagents, assays, and structural information for a specific research plan.
- Authored by a researcher at the University of Oxford, suggesting academic rigor.
- Released under an Open Access (green) license, facilitating reuse.
Limitations
- Row count and dataset size are unknown, which may limit suitability assessment.
- Column-level documentation is absent; field semantics must be inferred after download.
- Last update date is unknown; freshness unverified.
Provenance
- Source
- University of Oxford
- Collection Method
- Created as part of a drug discovery research plan.